Executive Summary of the 2025 World Allergy Organization Guidelines for Hereditary Angioedema
This Executive Summary is intended to provide a concise overview of the key concepts and recommendations of the 2025 World Allergy Organization Guidelines for Hereditary Angioedema. It should be read and cited in conjunction with the full guideline, which remains the primary source for the complete recommendations, supporting evidence, and methodological framework.1
Authors
- Darío Josviack (ORCID: https://orcid.org/0000-0002-6141-3525)
- Pablo Martínez (ORCID: https://orcid.org/0000-0002-8267-9410)
- Mário Morais‐Almeida (ORCID: https://orcid.org/0000-0003-1837-2980)
- Ignacio Javier Ansotegui (ORCID: https://orcid.org/0000-0002-6942-1511)
- Pedro Francisco Giavina-Bianchi Junior (ORCID: https://orcid.org/0000-0002-1034-7580)
- Claudio Fantini (ORCID: https://orcid.org/0000-0002-9173-0978)
- Timothy Craig (ORCID: https://orcid.org/0000-0002-7774-4855)
- Daniel Vázquez (ORCID: https://orcid.org/0000-0001-9864-0783)
- Allen P. Kaplan
- Jonathan A. Bernstein (ORCID: https://orcid.org/0000-0002-3476-1196)
- Bryan L. Martin
Institutions
- Pennsylvania State University (US)
- Medical University of South Carolina (US)
- Universidade de São Paulo (BR)
- Vinmec Times City International Hospital (VN)
- VinUniversity (VN)
- Hospital CUF Descobertas (PT)
- IDCQ Hospitales y Sanidad, S.L.U. (ES)
- Instituto Nacional de Ciência e Tecnologia de Investigação em Imunologia (BR)
- The Ohio State University (US)
- Universidad Nacional del Sur (AR)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2026-10-27
- DOI
- https://doi.org/10.1016/j.waojou.2026.101481
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00